SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+9.59%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$688M
AUM Growth
+$688M
(+9.4%)
Cap. Flow
+$4.88M
Cap. Flow
% of AUM
0.71%
Top 10 Holdings %
Top 10 Hldgs %
65.8%
Holding
28
New
2
Increased
16
Reduced
6
Closed
2
Top Buys
| 1 |
Biogen
BIIB
|
$15.7M |
| 2 |
Abbott
ABT
|
$10.6M |
| 3 |
Gilead Sciences
GILD
|
$7.07M |
| 4 |
Tenet Healthcare
THC
|
$6.25M |
| 5 |
Bristol-Myers Squibb
BMY
|
$5.96M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$29.2M |
| 2 |
Eli Lilly
LLY
|
$15.3M |
| 3 |
Masimo
MASI
|
$5.18M |
| 4 |
Elevance Health
ELV
|
$4.74M |
| 5 |
United Therapeutics
UTHR
|
$3.92M |
Sector Composition
| 1 | Healthcare | 98.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
26
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $4.9M | 0.71% | +40,300 | New | +$4.9M |
|
|
27
United Therapeutics
UTHR
$13.8B
| – | – | -28,974 | Closed | -$3.92M |
|
|
28
Vertex Pharmaceuticals
VRTX
$100B
| – | – | -267,050 | Closed | -$29.2M |
|